A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis

Conditions: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista ™ Sponsors: Synmosa Biopharma Corp. Completed

https://clinicaltrials.gov/study/NCT06051786

Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials